主要文件

查看所有文档

G7208

亚硫酸亚乙酯

Name: 亚硫酸亚乙酯
Brand: ALDRICH

98%

别名:

2-氧代-1,3,2-二氧硫杂戊烷, ES, 乙二醇亚硫酸盐, 环亚乙基亚硫酸盐

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:

C₂H₄O₃S

化学文摘社编号:

3741-38-6

分子量:

108.12

UNSPSC Code:

12352100

NACRES:

NA.22

PubChem Substance ID:

24895296

EC Number:

223-131-7

Beilstein/REAXYS Number:

1237109

MDL number:

MFCD00005354

Assay:

98%

Form:

liquid

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

assay

98%

form

liquid

greener alternative product characteristics

Design for Energy Efficiency
Learn more about the Principles of Green Chemistry.

sustainability

Greener Alternative Product

refractive index

n20/D 1.445 (lit.)

bp

159.1 °C (lit.)

density

1.426 g/mL at 25 °C (lit.)

greener alternative category

Enabling

SMILES string

O=S1OCCO1

InChI

1S/C2H4O3S/c3-6-4-1-2-5-6/h1-2H2

InChI key

WDXYVJKNSMILOQ-UHFFFAOYSA-N

说明

General description

We are committed to bringing you Greener Alternative Products, which belongs to one of the four categories of greener alternatives. This enabling product has been enhanced for energy efficiency. Click here for more information.

Still not finding the right product?

Explore all of our products under 亚硫酸亚乙酯

存储类别

10 - Combustible liquids

wgk

WGK 3

flash_point_f

197.1 °F

flash_point_c

91.7 °C

ppe

Eyeshields, Gloves, type ABEK (EN14387) respirator filter

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Lipidic dispersion to reduce food dependent oral bioavailability of fenofibrate: In vitro, in vivo and in silico assessments.

Joseph P O'Shea et al.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 96, 207-216 (2015-07-29)

Novel formulations that overcome the solubility limitations of poorly water soluble drugs (PWSD) are becoming ever more critical to a drug development process inundated with these compounds. There is a clear need for developing bio-enabling formulation approaches to improve oral

Development of novel docetaxel phospholipid nanoparticles for intravenous administration: quality by design approach.

Dharmendra K Yadav et al.

AAPS PharmSciTech, 16(4), 855-864 (2015-01-15)

The objective of this study was to develop novel docetaxel phospholipid nanoparticles (NDPNs) for intravenous administration. Modified solvent diffusion-evaporation method was adopted in the NDPN preparation. Central composite design (CCD) was employed in the optimization of the critical formulation factor

Lipid-based formulations solidified via adsorption onto the mesoporous carrier Neusilin® US2: effect of drug type and formulation composition on in vitro pharmaceutical performance.

Hywel D Williams et al.

Journal of pharmaceutical sciences, 103(6), 1734-1746 (2014-04-18)

The current study determined the extent to which the desorption of lipid-based formulations (LBFs) from a mesoporous magnesium aluminometasilicate (Neusilin®-US2) carrier is governed by drug properties, LBF composition, and LBF-to-adsorbent ratio. A secondary objective was to evaluate the impact of

查看所有相关文献

全球贸易项目编号

货号	GTIN
G7208-25G	04061832423319